Novartis Challenges $1.3M Verdict In Zometa Jaw Injury Suit

Law360, New York (September 23, 2013, 8:21 PM EDT) -- Novartis Pharmaceutical Corp. moved for a new trial Friday immediately after a Florida jury awarded $1.3 million in damages to a Zometa user who allegedly suffered jaw death, pointing to a perceived inconsistency in an original verdict scrapped by the court.

Friday's verdict against Novartis on negligent and strict liability failure-to-warn claims came after U.S. District Judge Gregory Presnell rejected the jury's verdict reached earlier that day because its finding against Novartis on the negligent failure-to-warn claim contradicted its finding for the company on the strict...
To view the full article, register now.